发明授权
US08759342B2 Benzo[1,4]oxazin-3-one, benzo[1,4]thiazin-3-one and quinolin-2-one urotensin II receptor antagonists
失效
苯并[1,4]恶嗪-3-酮,苯并[1,4]噻嗪-3-酮和喹啉-2-酮尿素调节素II受体拮抗剂
- 专利标题: Benzo[1,4]oxazin-3-one, benzo[1,4]thiazin-3-one and quinolin-2-one urotensin II receptor antagonists
- 专利标题(中): 苯并[1,4]恶嗪-3-酮,苯并[1,4]噻嗪-3-酮和喹啉-2-酮尿素调节素II受体拮抗剂
-
申请号: US11881268申请日: 2007-07-26
-
公开(公告)号: US08759342B2公开(公告)日: 2014-06-24
- 发明人: Ghosh Shyamali , William A Kinney , Edward C Lawson , Diane K Luci , Bruce E Maryanoff , Francois Maria Sommen
- 申请人: Ghosh Shyamali , William A Kinney , Edward C Lawson , Diane K Luci , Bruce E Maryanoff , Francois Maria Sommen
- 申请人地址: BE Beerse
- 专利权人: Janssen Pharmaceutica NV
- 当前专利权人: Janssen Pharmaceutica NV
- 当前专利权人地址: BE Beerse
- 代理商 Yuriy P. Stercho
- 主分类号: A61K31/535
- IPC分类号: A61K31/535 ; C07D265/36
摘要:
The invention is directed to benzo[1,4]oxazin-3-one, benzo[1,4]thiazin-3-one and quinolin-2-one Urotensin II receptor antagonists useful in treating or ameliorating a Urotensin-II mediated disorder. More specifically, the present invention relates to certain novel benzo[1,4]oxazin-3-one, benzo[1,4]thiazin-3-one and quinolin-2-one compounds and methods for preparing compounds, compositions, intermediates and derivatives thereof. Pharmaceutical compositions and methods for treating or ameliorating a Urotensin-II mediated disorder using compounds of the invention are also described.
公开/授权文献
- US20080039454A1 Urotensin II receptor antagonists 公开/授权日:2008-02-14